N
Nurix Therapeutics, Inc.
NRIX · NASDAQ · Healthcare · 2.8B
Price · close
$26.72
-1.22% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.3×
Enterprise value / EBITDAEV/EBITDA
-8.3×
Free cash flow yieldFCF yield
-11.9%
Return on equityROE
-49.1%
Operating margin
-340.2%
Net debt / EBITDAbalance-sheet strength
0.8×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.